QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units
QT Imaging Holdings, Inc. (NASDAQ: QTI), a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, updated the ticker symbol for its warrants to "QTIWW", currently trading in the over-the-counter (OTC) market, effective as of March 11, 2024. The company's units formerly trading in the OTC market under "GIAFU" have been delisted as of March 11, 2024, as each unit was split into one share of common stock and one warrant upon the closing of its business combination on March 4, 2024.
About QT Imaging Holdings, Inc.
QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient's experience. For more information on QT Imaging Holdings, Inc., please visit the company's website at www.qtimaging.com.
Global law firm Greenberg Traurig, P.A. advised OPKO Health Inc., a Miami-based multinational biopharmaceutical and diagnostics company, in the $237.5 million sale of select assets of its wholly owned subsidiary,...
Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical compounds, vaccines, cosmetics, and a wide array of...
The Global Ultrasound Institute (GUSI) is proud to announce the launch of the GUSI Fellowships Platform, an innovative online platform designed to empower learners around the world to achieve confidence and competency in point-of-care ultrasound...
Biohaven Ltd. (Biohaven), today announced that it will host a conference call to discuss topline data from Study BHV4157-206-RWE (NCT06529146), a study designed in discussion with the US Food and Drug Administration (FDA), to assess the...
BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce an increase to its previously announced non-brokered private placement offering of units of the Company ("Units") at a price of $0.05 per Unit (the "Private...
Report on how AI is redefining market landscape - The global soft tissue repair market size is estimated to grow by USD 3.29 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 4.2% during the forecast...
